{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:22:32Z","timestamp":1789352552244,"version":"build-2803163510"},"reference-count":18,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The in vitro activity of moxifloxacin against\n            <jats:italic>Coxiella burnetii<\/jats:italic>\n            was compared to those of pefloxacin, ofloxacin, and doxycycline. MICs of moxifloxacin ranged from 0.5 to 1 \u03bcg\/ml for the Nine Mile, Priscilla, and Q212 strains. Moxifloxacin was not bactericidal against\n            <jats:italic>C. burnetii<\/jats:italic>\n            at 4 \u03bcg\/ml.\n          <\/jats:p>","DOI":"10.1128\/aac.45.1.301-302.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:06:42Z","timestamp":1027764402000},"page":"301-302","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":25,"title":["Bacteriostatic and Bactericidal Activities of Moxifloxacin against\n            <i>Coxiella burnetii<\/i>"],"prefix":"10.1128","volume":"45","author":[{"given":"Jean-Marc","family":"Rolain","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Unite\u0301 des Rickettsies CNRS UPRES-A 6020, Faculte\u0301 de Me\u0301decine, Universite\u0301 de la Me\u0301diterrane\u0301e, 13385 Marseille Cedex 05, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Maurin","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Unite\u0301 des Rickettsies CNRS UPRES-A 6020, Faculte\u0301 de Me\u0301decine, Universite\u0301 de la Me\u0301diterrane\u0301e, 13385 Marseille Cedex 05, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Raoult","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Unite\u0301 des Rickettsies CNRS UPRES-A 6020, Faculte\u0301 de Me\u0301decine, Universite\u0301 de la Me\u0301diterrane\u0301e, 13385 Marseille Cedex 05, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00003495-199957030-00007","article-title":"Moxifloxacin.","volume":"57","author":"Balfour J. A.","year":"1999","unstructured":"Balfour J. A. Wiseman L. R. Moxifloxacin. Drugs 57 1999 363 374","journal-title":"Drugs"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.3.703"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.8.1818"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.42.10.2747","article-title":"In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.","volume":"42","author":"Gikas A.","year":"1999","unstructured":"Gikas A. Spyridaki I. Psaroulaki A. Kofterithis D. Tselentis Y. In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. Antimicrob. Agents Chemother. 42 1999 2747 2748","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ije\/22.5.945","article-title":"Q fever is absent from New Zealand.","volume":"22","author":"Kazar J.","year":"1993","unstructured":"Kazar J. Q fever is absent from New Zealand. Int. J. Epidemiol. 22 1993 945 949","journal-title":"Int. J. Epidemiol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/jac\/33.6.1254","article-title":"The inhibitory effect of fluoroquinolones on Coxiella burnetii growth in in-vitro systems.","volume":"33","author":"Keren G.","year":"1994","unstructured":"Keren G. Keysary A. Goldwasser R. Rubinstein E. The inhibitory effect of fluoroquinolones on Coxiella burnetii growth in in-vitro systems. J. Antimicrob. Chemother. 33 1994 1254 1255","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.5.1097"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.4.518"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/jac\/39.6.725","article-title":"Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii,Rickettsia conorii, \u201cIsraeli spotted fever group rickettsia\u201d and Coxiella burnetii.","volume":"39","author":"Maurin M.","year":"1997","unstructured":"Maurin M. Raoult D. Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii,Rickettsia conorii, \u201cIsraeli spotted fever group rickettsia\u201d and Coxiella burnetii. J. Antimicrob. Chemother. 39 1997 725 730","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/AAC.43.1.12","article-title":"Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells.","volume":"43","author":"Pascual A.","year":"1999","unstructured":"Pascual A. Garcia I. Ballesta S. Perea E. J. Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells. Antimicrob. Agents Chemother. 43 1999 5 12","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.8.1512"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.10.2070"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0924-8579(99)00057-6","article-title":"Activity of grepafloxacin and other fluoroquinones and newer macrolides against recent clinical isolates of Chlamydia pneumoniae.","volume":"12","author":"Roblin P. M.","year":"1999","unstructured":"Roblin P. M. Kutlin A. Reznik T. Hammerschlag M. R. Activity of grepafloxacin and other fluoroquinones and newer macrolides against recent clinical isolates of Chlamydia pneumoniae. Int. J. Antimicrob. Agents 12 1999 181 184","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.6.1520"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.6.835"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90173-9"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/43.suppl_2.91","article-title":"Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone.","volume":"43","author":"Von Keutz E.","year":"1999","unstructured":"Von Keutz E. Schluter G. Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone. J. Antimicrob. Chemother. 43 1999 91 100","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.7.1079"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.1.301-302.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.1.301-302.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:00:24Z","timestamp":1645462824000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.45.1.301-302.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1128\/AAC.45.1.301-302.2001"],"URL":"https:\/\/doi.org\/10.1128\/aac.45.1.301-302.2001","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]},"assertion":[{"value":"2000-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-09-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}